India — Crustaceans and Products Thereof

← back to leaderboard

India received 19 RASFF border-rejection notifications in Crustaceans and Products Thereof between 2023-Q2 and 2026-Q1. Volume peaked at 3 in 2023-Q2, with the trend rising sharply year-on-year. The most-cited issues are nitrofuran (metabolite) furazolidone (AOZ), nitrofuran (metabolite) nitrofurazone (SEM), and furazolidon.

Quarterly rejections, last 12 quarters

3 2023-Q2 2023-Q2: 3 0 2023-Q3 2023-Q3: 0 0 2023-Q4 2023-Q4: 0 1 2024-Q1 2024-Q1: 1 1 2024-Q2 2024-Q2: 1 2 2024-Q3 2024-Q3: 2 1 2024-Q4 2024-Q4: 1 1 2025-Q1 2025-Q1: 1 2 2025-Q2 2025-Q2: 2 3 2025-Q3 2025-Q3: 3 2 2025-Q4 2025-Q4: 2 3 2026-Q1 2026-Q1: 3

Recent rejections